Baltimore City Council
File #: 17-0055R    Version: 0 Name: Prescription Drug Affordability Initiative
Type: City Council Resolution Status: Adopted
File created: 12/4/2017 In control: City Council
On agenda: Final action: 12/4/2017
Enactment #:
Title: Prescription Drug Affordability Initiative For the purpose of supporting the goals of the Maryland Citizens’ Health Initiative and calling on the State of Maryland to implement its 3 commonsense ideas to improve our citizens’ access to essential prescription drugs.
Sponsors: Mary Pat Clarke, President Young, Ryan Dorsey, Brandon M. Scott, Eric T. Costello, Kristerfer Burnett, Leon F. Pinkett, III, John T. Bullock, Isaac "Yitzy" Schleifer, Shannon Sneed, Zeke Cohen, Sharon Green Middleton, Bill Henry, Robert Stokes, Sr.
Indexes: Affordability, Initiative, Prescription Medications
Attachments: 1. 17-0055R~1st Reader, 2. Completed Legislative File 17-0055R
* Warning: This is an unofficial, introductory copy of the bill.
The official copy considered by the City Council is the first reader copy.
Introductory*

City of Baltimore
Council Bill R
(Resolution)

Introduced by: Councilmember Clarke



A Resolution Entitled

A Council Resolution concerning
title
Prescription Drug Affordability Initiative
For the purpose of supporting the goals of the Maryland Citizens’ Health Initiative and calling on the State of Maryland to implement its 3 commonsense ideas to improve our citizens’ access to essential prescription drugs.
body

Recitals

Whereas, to protect our lives and our well-being, every family in Maryland requires access to affordable prescription drugs.

Whereas, skyrocketing costs are making some medicines virtually inaccessible to our families and neighbors.

Whereas, overall drug prices increased almost 9% in 2016 while general inflation increased just over 2% in the same period, and since 2013 drug prices have risen an average of 10% annually but inflation has only increased 1.2% on average since 2013.

Whereas, prescription drug spending accounted for over 22% of each health insurance premium dollar in 2014, and nearly a quarter of people in their deductible period never picked up their prescriptions from the pharmacy, presumably because of the cost.

Whereas, there are pharmacy benefit managers who reportedly ban pharmacists from discussing lower-priced drug choices with their patients.

Whereas, Maryland should continue to lead the Nation in addressing the affordability of prescription drugs, building on the State's landmark 2017 legislation banning price gouging by manufacturers of gene...

Click here for full text